Life Sciences Report March 2020 – Drug Safety

Clinical Professionals and Vacancysoft

March 2020

For Pharmaceuticals companies, 2020 faces its own unique challenges. Already there are multiple blockbuster drugs due to expire this year, including Lucentis produced by Roche & Novartis, along with Spyrcel. Now with the advent of the Coronavirus crisis, companies will be under pressure like never before to release a drug quickly that can act as a vaccine.

Therefore, we already see that drug safety vacancies have been continuously increasing across the EU27. Since 2018 the number of vacancies had increased by 24.8%. However, perhaps due to a Brexit drag, in the UK specifically, the number of pharmacovigilance vacancies has dropped by 5.8%.

To find out more about the latest trends in the Drug Safety, download the report now!

Yes, I want this report!

    Yes, I would like to receive more information about your products, offers, and events. I understand I can unsubscribe at any time.*

    When you provide the information above, we will use it to process your request as described in our Privacy Policy .

    Related Posts

    Marketing in Finance – UK Finance Labour Mar... How are vacancies for marketing faring through the skills shortage in the UK? Which regions are leading in recruitment professionals and which firms h...
    Quality Assurance & Engineering — UK Life Sci... How are vacancies for QA scientists and Engineers in the Life Sciences industry navigating the challenging political and economic landscape? What are ...